TTY Biopharm Company Limited

TTY Biopharm Company Limited

4105.TWO
TTY Biopharm Company LimitedTW flagTaipei Exchange
78.20
TWD
+0.30
- -
19.44BMarket Cap

TTY Biopharm Company Limited (4105.TWO) Stock Split History

Learn about TTY Biopharm Company Limited's most recent 1067-for-1000 basis stock split on August 13, 2014. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about TTY Biopharm Company Limited's most recent stock split

Split Date: 2014-08-13
Split Ratio: 1067:1000
Price Before Split: $73.52
Price After Split: $68.90

Developer API

Get 4105.TWO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/4105.TWO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.07 times more shares (a 1067:1000 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of TTY Biopharm Company Limited's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2014-08-131067:1000No$73.52$68.90
2013-08-201089:1000No$101.38$93.10
2012-08-1331:25No$133.31$107.50
2011-07-29617:500No$162.88$131.99
2010-09-20109:100No$157.50$144.50
2009-07-31117:100No$130.45$111.49
2008-08-2059:50No$45.24$38.34
2007-08-211091:1000No$50.50$46.29
2006-08-1011:10No$30.02$27.29

About TTY Biopharm Company Limited

Company overview and industry information

TTY Biopharm Company Limited (4105.TWO) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1067-for-1000 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to TTY Biopharm Company Limited Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.